#ShockwaveIVL’s# clinical evidence is different. Our predictably safe and consistently effective MOA has been validated by nearly 25,000 published patient outcomes across more than 600 scientific publications. To date, we have supported more than 70 company-led and investigator-initiated clinical studies, with an additional 50 planned between 2025 and 2029. Each study is designed to reflect the complex scenarios physicians encounter every day and to generate the clinical evidence needed to support confident adoption of Shockwave IVL. Read this new Cardiac Interventions Today article by our CMO, Nick West, to learn what our relentless commitment to research means for the future of calcium modification:  US Rx only. Safety Info:  availability may vary by country.

#ShockwaveC2Aero# continues to make waves across Northern UK and Ireland! With improved deliverability and a fast procedural flow, Shockwave C2 Aero is designed to reach and treat even the most challenging calcified coronary lesions. These first cases mark more than a launch milestone. They reflect #ShockwaveIVL’s# commitment to innovation and serve as a powerful reminder of what innovation is truly for, making complex care more achievable, consistent, and patient centered. We're proud to stand alongside UK and Irish interventional cardiologists in tackling complex coronary calcium. US Rx only. Safety Info: ​ Product availability may vary by country.

Joining CITIC2026? Don’t miss our #ShockwaveIVL# symposium! Led by Prof. Flavio Ribichini (@FlavioRibichini), Dr. Carla Agatiello (@CarlaAgatiello), and Dr. Félix Damas (@felixdamasds), this session will explore the role of Shockwave IVL in addressing complex coronary calcium. Discover key insights from EMPOWER CAD and gain a deeper understanding of how Shockwave IVL performs in challenging lesions. Save the date and join the discussion as we advance the standard of care in coronary intervention. Presenting physicians are paid consultants of Shockwave Medical. US Rx only. Safety Info: ​Product availability may vary by country.

Headed to #AMP2026#? Tomorrow's session is one you won't want to miss. Drs. Micah Watts (@Watts_IR), John Winscott and Michael Siah (@michaelcsiah) are hosting an interactive #ShockwaveIVL# symposium featuring case presentations and wave-making discussion. From procedural planning to device choice, you'll leave thinking differently about how to tackle calcified peripheral arterial disease. See you there! @AMPSymposium US Rx only. Safety Info: Product availability may vary by country.

When treating challenging calcified nodules, Shockwave C2 Aero delivers ▶️ Watch Dr Nieves Gonzalo share her experience using #ShockwaveC2Aero# in a patient with a calcified nodule in the ostial and mid LAD. Learn how the device's enhanced crossability and catheter rewrap capability provided the flexibility to navigate the procedure with confidence and re-advance when needed. We're honored to be part of cases that help physicians address complex coronary calcified lesions and advance patient care every day. Congratulations to Dr Gonzalo on this successful treatment. #ShockwaveIVL# #ShockwaveC2Aero# #FirstCases# #CalcifiedNodule# Dr Nieves Gonzalo is a paid consultant for Shockwave Medical. US Rx only. Safety Info:  Product availability may vary by country.

#AMP2026# is a wrap! Thank you to everyone who joined our #ShockwaveIVL# symposium. We hope the case-based insights and expert perspectives spark new possibilities in your approach to patient care. A special thank you to Drs. Micah Watts (@Watts_IR), John Winscott and Michael Siah (@michaelcsiah) for sharing their expertise and helping make this session such a success. We appreciate you! Presenting physicians are paid consultants of Shockwave Medical. US Rx only. Safety Info: Product availability may vary by country.

#AMP2026# attendees — join us Friday, August 7 at 12:45 PM for our #ShockwaveIVL# symposium, Case Based Strategies for Treating Peripheral Arterial Calcification Across Multiple Vessel Beds. Drs. Micah Watts (@Watts_IR), John Winscott and Michael Siah (@michaelcsiah) will break down real-world cases and show how our expanding portfolio can help crack calcium wherever you find it. Add this energizing session to your agenda today. @AMPSymposium US Rx only. Safety Info: Product availability may vary by country.

What difference can better trackability make in the cath lab? ▶️ Watch Prof. Dr. Med. Michael Haude’s testimony on his first experience using #ShockwaveC2Aero#. The improved trackability helped Prof. Haude navigate tighter lesions more easily, while enhanced emitter visibility provided greater confidence throughout the procedure. Additionally, the shortened interval between every ten pulse deliveries, now reduced to just 5 seconds, contributed to a smoother workflow. At Shockwave, we are committed to advancing technologies that support physicians treating calcified lesions. Congratulations to Prof. Dr. Med. Haude on this amazing first case using Shockwave C2 Aero. #ShockwaveIVL# #ShockwaveC2Aero# #FirstCases# #Trackability# Prof. Dr. Med. Michael Haude is a paid consultant for Shockwave Medical. Compared to Shockwave C2+ device. US Rx only. Safety Info:  Product availability may vary by country.

What if you could cross a tight calcified lesion without aggressive pre-dilatation? ▶️ Watch Dr. Gabriele Gasparini share how #ShockwaveC2Aero# supported his procedure, enabling him to start therapy delivery from proximal to distal in a challenging calcified lesion. Thanks to the catheter's crossability and trackability, lesion access was achieved without the need for excessive force, helping facilitate therapy delivery when it mattered most. We are proud to partner with physicians tackling some of the most complex calcified lesions every day. Congratulations to Dr Gasparini on this outstanding results. #ShockwaveIVL# #ShockwaveC2Aero# #FirstCases# #Crossability# Dr Gabriele Gasparini is a paid consultant for Shockwave Medical. US Rx only. Safety Info:  Product availability may vary by country.

When is #ShockwaveIVL# a suitable treatment for calcific coronary artery disease? Consult CALC!​ Shockwave IVL’s unique MOA and proven safety, effectiveness and ability to modify all types of calcium make it a good candidate for calcium modification in many scenarios.​ Swipe to learn more, and visit the CALC webpage for a deep dive:   ​ US Rx only. Safety Info: ​ Product availability may vary by country.